DSpace Home
→
Browsing by Author

Browsing by Author "van Doorn H.C."

Now showing items 1-3 of 3

Factors Predicting 30-Day Grade IIIa–V Clavien–Dindo Classification Complications and Delayed Chemotherapy Initiation after Cytoreductive Surgery for Advanced-Stage Ovarian Cancer: A Prospective Cohort Study

Kengsakul M.; Nieuwenhuyzen-de Boer G.M.; Udomkarnjananun S.; Kerr S.J.; van Doorn H.C.; van Beekhuizen H.J. (MDPI, 2022)

Objective: The aim of this study was to evaluate factors associated with 30-day postoperative Clavien–Dindo classification (CDC) grade IIIa or greater complications and delayed initiation of chemotherapy after cytoreductive ...
The efficacy of topical imiquimod in high-grade cervical intraepithelial neoplasia: A systematic review and meta-analysis

van de Sande A.J.M.; Kengsakul M.; Koeneman M.M.; Jozwiak M.; Gerestein C.G.; Kruse A.J.; van Esch E.M.G.; de Vos van Steenwijk P.J.; Muntinga C.L.P.; Bramer W.M.; van Doorn H.C.; van Kemenade F.J.; van Beekhuizen H.J. (John Wiley and Sons Ltd, 2023)

Objective: A major side effect of cervical excision for high-grade cervical intraepithelial neoplasia (CIN) is premature birth. A non-invasive treatment for reproductive age women is warranted. The aim of the present study ...
Unresectable Ovarian Cancer Requires a Structured Plan of Action: A Prospective Cohort Study

Nieuwenhuyzen-de Boer G.M.; Kengsakul M.; Boere I.A.; van Doorn H.C.; van Beekhuizen H.J. (MDPI, 2023)

Background: Patients with unresectable disease during cytoreductive surgery (CRS) for advanced-stage ovarian cancer are underreported. Knowledge of treatment and survival after surgery is limited. The aim of this study is ...

Now showing items 1-3 of 3

Search DSpace

Advanced Search

Browse

All of DSpace

Browsing by Author "van Doorn H.C."

Browsing by Author "van Doorn H.C."

Search DSpace

Browse

All of DSpace

My Account